X-Received: by 2002:a05:6214:ca6:b0:472:e7e6:13a2 with SMTP id s6-20020a0562140ca600b00472e7e613a2mr7796938qvs.69.1656933348202;
Mon, 04 Jul 2022 04:15:48 -0700 (PDT)
X-Received: by 2002:a81:b44:0:b0:31c:8a14:8c6e with SMTP id
65-20020a810b44000000b0031c8a148c6emr8024587ywl.40.1656933347954; Mon, 04 Jul
2022 04:15:47 -0700 (PDT)
Path: i2pn2.org!i2pn.org!weretis.net!feeder6.news.weretis.net!news.misty.com!border2.nntp.dca1.giganews.com!nntp.giganews.com!news-out.google.com!nntp.google.com!postnews.google.com!google-groups.googlegroups.com!not-for-mail
Newsgroups: comp.os.vms
Date: Mon, 4 Jul 2022 04:15:47 -0700 (PDT)
Injection-Info: google-groups.googlegroups.com; posting-host=104.223.104.235; posting-account=hkCnjwoAAAD931FDYXyewH5MrRYaKfqN
NNTP-Posting-Host: 104.223.104.235
User-Agent: G2/1.0
MIME-Version: 1.0
Message-ID: <63d1f54a-253e-4826-ad9d-7f3b65b2830an@googlegroups.com>
Subject: (PDF) Optimization in Drug Discovery - In Vitro Methods 2nd Edition
by Caldwell
From: hesterho...@gmail.com (Hester Holt)
Injection-Date: Mon, 04 Jul 2022 11:15:48 +0000
Content-Type: text/plain; charset="UTF-8"
Lines: 1